Victory Capital Management Inc Avalo Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$3.0 - $10.45 $46,230 - $161,034	-15,410 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$7.57 - $21.72 $3,323 - $9,535	-439 Reduced 2.77%	15,410 $6,000
Q4 2021 Feb 07, 2022	BUY	$19.68 - $28.68 $1,200 - $1,749	61 Added 0.39%	15,849 $27,000
Q3 2021 Nov 02, 2021	BUY	$26.16 - $40.68 $413,014 - $642,255	15,788 New	15,788 $34,000

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $91.6M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.